These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 29031197)

  • 21. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis.
    Zecchin KG; Rossato FA; Raposo HF; Melo DR; Alberici LC; Oliveira HC; Castilho RF; Coletta RD; Vercesi AE; Graner E
    Lab Invest; 2011 Feb; 91(2):232-40. PubMed ID: 20805790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoalantolactone induces apoptosis in human breast cancer cells via ROS-mediated mitochondrial pathway and downregulation of SIRT1.
    Li Z; Qin B; Qi X; Mao J; Wu D
    Arch Pharm Res; 2016 Oct; 39(10):1441-1453. PubMed ID: 27600429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leucine deprivation inhibits proliferation and induces apoptosis of human breast cancer cells via fatty acid synthase.
    Xiao F; Wang C; Yin H; Yu J; Chen S; Fang J; Guo F
    Oncotarget; 2016 Sep; 7(39):63679-63689. PubMed ID: 27579768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers.
    Uddin S; Siraj AK; Al-Rasheed M; Ahmed M; Bu R; Myers JN; Al-Nuaim A; Al-Sobhi S; Al-Dayel F; Bavi P; Hussain AR; Al-Kuraya KS
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4088-97. PubMed ID: 18682509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells.
    Schroeder B; Vander Steen T; Espinoza I; Venkatapoorna CMK; Hu Z; Silva FM; Regan K; Cuyàs E; Meng XW; Verdura S; Arbusà A; Schneider PA; Flatten KS; Kemble G; Montero J; Kaufmann SH; Menendez JA; Lupu R
    Cell Death Dis; 2021 Oct; 12(11):977. PubMed ID: 34675185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel agent exerts antitumor activity in breast cancer cells by targeting mitochondrial complex II.
    Wang L; Zhang X; Cui G; Chan JY; Wang L; Li C; Shan L; Xu C; Zhang Q; Wang Y; Di L; Lee SM
    Oncotarget; 2016 May; 7(22):32054-64. PubMed ID: 27081033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sanguinarine, a benzophenanthridine alkaloid, induces apoptosis in MDA-MB-231 human breast carcinoma cells through a reactive oxygen species-mediated mitochondrial pathway.
    Choi WY; Kim GY; Lee WH; Choi YH
    Chemotherapy; 2008; 54(4):279-87. PubMed ID: 18667818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment.
    Salimi V; Shahsavari Z; Safizadeh B; Hosseini A; Khademian N; Tavakoli-Yaraki M
    Lipids Health Dis; 2017 Nov; 16(1):208. PubMed ID: 29096636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model.
    Carvalho MA; Zecchin KG; Seguin F; Bastos DC; Agostini M; Rangel AL; Veiga SS; Raposo HF; Oliveira HC; Loda M; Coletta RD; Graner E
    Int J Cancer; 2008 Dec; 123(11):2557-65. PubMed ID: 18770866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents.
    Pons DG; Torrens-Mas M; Nadal-Serrano M; Sastre-Serra J; Roca P; Oliver J
    Int J Biochem Cell Biol; 2015 Sep; 66():85-94. PubMed ID: 26232188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype.
    Kant S; Kumar A; Singh SM
    Biochim Biophys Acta; 2014 Jan; 1840(1):294-302. PubMed ID: 24060750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Inhibitor of Fatty Acid Synthase Thioesterase Domain with Improved Cytotoxicity against Breast Cancer Cells and Stability in Plasma.
    Lupien LE; Dunkley EM; Maloy MJ; Lehner IB; Foisey MG; Ouellette ME; Lewis LD; Pooler DB; Kinlaw WB; Baures PW
    J Pharmacol Exp Ther; 2019 Oct; 371(1):171-185. PubMed ID: 31300609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells.
    Bollu LR; Ren J; Blessing AM; Katreddy RR; Gao G; Xu L; Wang J; Su F; Weihua Z
    Cell Cycle; 2014; 13(15):2415-30. PubMed ID: 25483192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans.
    Li L; Che L; Tharp KM; Park HM; Pilo MG; Cao D; Cigliano A; Latte G; Xu Z; Ribback S; Dombrowski F; Evert M; Gores GJ; Stahl A; Calvisi DF; Chen X
    Hepatology; 2016 Jun; 63(6):1900-13. PubMed ID: 26910791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and anticancer activity of some novel 1H-benzo[d]imidazole-5-carboxamide derivatives as fatty acid synthase inhibitors.
    Singh S; Paul S; Brás NF; Kundu CN; Karthikeyan C; Moorthy NSHN
    Bioorg Chem; 2023 Sep; 138():106658. PubMed ID: 37331170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
    Vazquez-Martin A; Colomer R; Brunet J; Menendez JA
    Int J Oncol; 2007 Oct; 31(4):769-76. PubMed ID: 17786307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Fatty Acid Synthase Reduces Blastocyst Hatching through Regulation of the AKT Pathway in Pigs.
    Guo J; Kim NH; Cui XS
    PLoS One; 2017; 12(1):e0170624. PubMed ID: 28107461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Palmitate induced mitochondrial deoxyribonucleic acid damage and apoptosis in l6 rat skeletal muscle cells.
    Rachek LI; Musiyenko SI; LeDoux SP; Wilson GL
    Endocrinology; 2007 Jan; 148(1):293-9. PubMed ID: 17023529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.